PMCTPharmaCountry
    Startseite

Regulatorische Updates

Regulatorische Entwicklungen von FDA, EMA, TGA und weltweit

#Scilex Pharmaceuticals ×

UPDATED
Regulatorische Updates
24. Sept. 2026•1 Min. Lesezeit
FDA Approves GLOPERBA Oral Colchicine Solution (NDA 210942)
Scilex Pharmaceuticals' GLOPERBA, an oral colchicine solution (0.6 mg/5 mL), received FDA approval under NDA 210942, with supplemental updates in 2021 and 2024.